How Much Did DEXLEVO Raise?
Funding & Key Investors

DEXLEVO, a South Korean supplier of aesthetic medical products, has secured $22M in total capital, with its most recent financing round on December 6, 2021, bringing in $22M through a major strategic investment. This enterprise-level funding underscores the company's significant traction in the biopolymer technology sector, particularly for advanced skin care solutions.

What is DEXLEVO?

DEXLEVO
ManufacturingPharmaceuticalsCosmetics, Beauty Supply & Personal Care Products

Founded in 2012 and headquartered in Seoul, South Korea, DEXLEVO operates within the aesthetic medical products market. The company's core expertise lies in biopolymer technology, which it applies to develop innovative solutions for skin care. This specialization positions DEXLEVO at the intersection of medical technology and the rapidly growing beauty and wellness industry, leveraging scientific advancements for cosmetic and therapeutic applications.

How much funding has DEXLEVO raised?

DEXLEVO has raised a total of $22M across 1 funding round:

2021

Other Financing Round

$22M

Other Financing Round (2021): $22M with participation from Smilegate Investment, Shinhan Financial Group, Magna Investment, and HYUNDAI VENTURE INVESTMENT

Key Investors in DEXLEVO

Smilegate Investment

Smilegate Investment is an investment firm that has participated in DEXLEVO's funding round. Further details on their specific investment focus are not provided in the available data.

Shinhan Financial Group

Shinhan Financial Group is a comprehensive financial services organization providing banking, investment, and financial management solutions. Their participation suggests a strategic interest in the company's growth trajectory and market potential.

Magna Investment

Magna Investment is a private investment firm focused on building sustainable growth across various asset classes. Their involvement in DEXLEVO's funding round indicates a strategic alignment with the company's long-term objectives and market positioning.

What's next for DEXLEVO?

The substantial enterprise-level funding and strategic investment indicate DEXLEVO is poised for significant expansion and further development of its biopolymer technology. This capital infusion is likely to fuel research and development initiatives, enhance manufacturing capabilities, and broaden market reach, both domestically and internationally. The company's focus on advanced skin care solutions suggests a strategic push to capture a larger share of the global aesthetic medicine market, potentially through new product launches or strategic partnerships.

See full DEXLEVO company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturingGrocery RetailRetail
Industrial Machinery & EquipmentManufacturingConsumer ServicesRepair Services
Hand, Power & Lawn-care ToolsManufacturingIndustrial Machinery & Equipment
Boats & SubmarinesManufacturing

Frequently Asked Questions Regarding DEXLEVO Financial Insights

What are the most recent funding rounds that DEXLEVO has completed, and what were the funding rounds?
DEXLEVO has recently completed 1 funding rounds: Other Financing Round on Dec 6, 2021.
What is the total amount of funding DEXLEVO has raised to date?
DEXLEVO has raised a total of $22M in funding to date.
How many funding rounds has DEXLEVO completed?
DEXLEVO has completed 1 funding rounds.
How much funding did DEXLEVO raise in its most recent funding round?
DEXLEVO raised $22M in its most recent funding round.
Who are the lead investors in DEXLEVO's latest funding round?
The lead investor in DEXLEVO's latest funding round was Smilegate Investment. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in DEXLEVO's history?
The largest funding round in DEXLEVO's history was $22M.
See more information about DEXLEVO